| Maechell Ritter, | |
|
145 S Worthen St, Wenatchee, WA 98801-3081 | |
| (509) 662-6761 | |
| (509) 663-3182 |
| Full Name | Maechell Ritter |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 145 S Worthen St, Wenatchee, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336527670 | NPI | - | NPPES |
| 2092198 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LW60813242 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maechell Ritter, 145 S Worthen St, Wenatchee, WA 98801-3081 Ph: (509) 662-6761 | Maechell Ritter, 145 S Worthen St, Wenatchee, WA 98801-3081 Ph: (509) 662-6761 |
News Archive
Since the classical studies of Jacob and Monod in the early 1960s, it has been evident that genome sequences contain not only blueprints for genes and the proteins that they encode, but also the instructions for a coordinated regulatory program that governs when, where and to what extent these genes and proteins are expressed.
What used to be an annual exercise - waiting to see whether and by how much Congress would increase payments to physicians under Medicare - has now become a more frequent and even more frustrating activity for physicians.
Americans earn a failing grade on diabetes awareness, based on survey results released today by the American Diabetes Association. In general, Americans earned a 51% when asked a series of questions about a disease so common that it strikes every 20 seconds. The survey results revealed that many diabetes myths and misconceptions still exist, while the disease's prevalence continues to rise.
Zealand Pharma A/S, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs, is pleased to announce that its partner, sanofi-aventis, today announced that the GetGoal-X Phase III study of lixisenatide, a once-daily GLP-1 receptor agonist licensed from Zealand Pharma, achieved its primary endpoint of non-inferiority in HbA1c reduction from baseline, compared with exenatide twice-daily.
› Verified 9 days ago
Heidi Jo Crawford, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Nesha Bremmeyer, MSW, LSWAIC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 640 S Mission St, Wenatchee, WA 98801 Phone: 509-662-6761 | |
Sandra L Mcelearney, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Charles Riseley, LMHC Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 140 Easy Way, Wenatchee, WA 98801 Phone: 509-662-4296 | |
Joy Marie Osborn, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 145 S Worthen St, Wenatchee, WA 98801 Phone: 509-662-6761 | |
Ivonne Garcia Sanchez, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 504 Orondo Ave Ste A, Wenatchee, WA 98801 Phone: 509-662-1269 |